Table 2.
Comparison of NK cell, and B cell among control and URSA
| Cohort | Control(35) | URSA(269) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | Mean | Median | Range | SD | Mean | Median | Range | SD | |
| NK(%)* | 10.56 | 10.24 | 6.10–18.64 | 2.71 | 20.20 | 19.91 | 3.34–40.50 | 5.34 | 0.000 |
| CD3+CD56+(%) | 5.7 | 4.9 | 1.02–23.17 | 4.48 | 5.33 | 4.68 | 0.38–27.64 | 3.37 | 0.971 |
| CD56dimCD16+(%) | 92.71 | 95.12 | 74.75–99.17 | 6.91 | 95.86 | 97.27 | 70.87–99.72 | 4.08 | 0.006 |
| CD56brightCD16-(%) | 2.31 | 2.03 | 0.31–6.62 | 1.59 | 1.81 | 1.38 | 0.00–11.41 | 1.53 | 0.052 |
| B-cell | 13.05 | 12.21 | 6.06–24.58 | 4.32 | 12.17 | 11.86 | 1.78–41.99 | 4.57 | 0.207 |
| CD19+CD5+B | 18.68 | 11.66 | 2.80–59.49 | 15.55 | 14.16 | 12.23 | 0.52–59.62 | 9.86 | 0.409 |
Note. : 0.05.